Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,419 public trials 1,034 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Completed

CAMELLIA: Anti-CD47 Antibody Therapy in Haematological Malignancies

NCT02678338

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations
  • University Hospital of Wales Cardiff, United Kingdom
  • St. James University Hospital Leeds, United Kingdom
  • The Royal Liverpool University Hospital Liverpool, United Kingdom
  • The Christie NHS Foundation Trust Manchester, United Kingdom
View Trial Details
Completed

Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia

NCT00416598

Conditions
Acute Myeloid Leukemia, Acute Myeloid Leukemia With Myelodysplasia-Related Changes, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, +12 more
Locations
  • UCSF Medical Center-Mount Zion San Francisco, California, United States
  • Beebe Medical Center Lewes, Delaware, United States
  • Christiana Care Health System-Christiana Hospital Newark, Delaware, United States
  • Florida Hospital Orlando Orlando, Florida, United States
View all 46 locations
View Trial Details
Completed

A Study to Assess AC220 Given in Combination With Induction and Consolidation Therapy in Newly Diagnosed Acute Myeloid Leukemia (AML)

NCT01390337

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
Locations
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
  • Northwestern University Chicago, Illinois, United States
  • Johns Hopkins Medical Institute Baltimore, Maryland, United States
  • Memorial-Sloan Kettering Cancer Center New York, United States
View Trial Details
Completed

A Study of AC220 Given After Transplant in Subjects With Acute Myeloid Leukemia (AML)

NCT01468467

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
Locations
  • City of Hope Duarte, California, United States
  • Northwestern University Chicago, Illinois, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • M.D. Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)

NCT01687387

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • CHU d'Amiens Amiens, France
  • CHU Angers Angers, France
  • Centre hospitalier Victor Dupouy Argenteuil, France
  • Centre hospitalier de la côte Basque Bayonne, France
View all 43 locations
View Trial Details
Completed

Decitabine Followed by Mitoxantrone Hydrochloride, Etoposide, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

NCT01729845

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +6 more
Locations
  • Kadlec Clinic Hematology and Oncology Kennewick, Washington, United States
  • EvergreenHealth Medical Center Kirkland, Washington, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

Observational Study in CLL Patients Receiving BR

NCT02381899

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Department of Hematology - Oncology, University Hospital Brno, Czechia
  • 4th Department of Medicine - Hematology, University Hospital Hradec Králové, Czechia
  • Department of Hematology, University Hospital Pilsen, Czechia
  • Department of Medicine - Hematology, University Hospital Kralovske Vinohrady Prague, Czechia
View Trial Details

Related conditions